TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer

Joanna Bogusławska1, Katarzyna Rodzik1, Piotr Popławski1

  • 1Department of Biochemistry and Molecular Biology, Centre of Postgraduate Medical Education, ul. Marymoncka 99/103, 01-813 Warsaw, Poland.

Cancer Letters
|October 29, 2017
PubMed

Insights

MicroRNAs regulate gene expression and are disturbed in renal tumors, impacting cellular adhesion. TGF-β1 coordinates this microRNA network, correlating with poor patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Altered expression of 19 adhesion-related genes was previously observed in renal tumors.
  • MicroRNAs (miRNAs), short non-coding RNAs, regulate gene expression and were hypothesized to influence these adhesion gene alterations.

Purpose of the Study:

  • To investigate the role of microRNAs in regulating adhesion-related genes in renal tumors.
  • To identify specific microRNAs targeting adhesion genes and their functional impact on renal cancer cells.
  • To explore the relationship between microRNA expression, TGF-β1, and patient survival.

Main Methods:

  • Analysis of microRNA expression in renal tumors.
  • Prediction and validation of microRNA targets among adhesion-related genes.
  • Functional assays assessing the impact of specific microRNAs on cancer cell proliferation, adhesion, and migration.
  • Correlation analysis of microRNA and target gene expression with TGF-β1 levels and patient survival data.

Main Results:

  • Expression of 24 microRNAs targeting adhesion genes was disturbed in renal tumors and correlated with their targets.
  • miR-25-3p, miR-30a-5p, miR-328, and miR-363-3p were identified as direct regulators of key adhesion genes (e.g., COL5A1, ITGA5).
  • Specific microRNAs demonstrated distinct functional roles: miR-363-3p and miR-328 inhibited proliferation, while miR-25-3p affected adhesion, proliferation, and migration.
  • A significant correlation network was found between analyzed microRNAs, target genes, and TGF-β1 in patient tissues.
  • MicroRNA expression signatures linked to TGF-β1 levels correlated with poorer patient survival.

Conclusions:

  • Disturbed microRNA expression is implicated in altered cellular adhesion in renal tumors.
  • TGF-β1 plays a crucial role in coordinating a microRNA network that regulates cellular adhesion processes in cancer.
  • This microRNA-TGF-β1 network represents a potential prognostic biomarker and therapeutic target in renal cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K